NVIDIA
NVDA
Tesla
TSLA
Taiwan Semiconductor
TSM
4
Palantir
PLTR
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
RNA Avidity Biosciences
- 28.250
- -0.970-3.32%
Trading Mar 4 10:32 ET
3.40BMarket Cap-9.78P/E (TTM)
28.430High27.710Low294.35KVolume28.310Open29.220Pre Close8.25MTurnover0.32%Turnover RatioLossP/E (Static)120.21MShares56.00052wk High2.38P/B2.62BFloat Cap20.80052wk Low--Dividend TTM92.68MShs Float56.000Historical High--Div YieldTTM2.46%Amplitude4.825Historical Low28.042Avg Price1Lot Size
Avidity Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 152.20%1.5B | 152.20%1.5B | 192.78%1.59B | 125.33%1.3B | 56.21%915.87M | -2.52%595.35M | -2.52%595.35M | 33.79%542.58M | 44.77%576.5M | 47.66%586.3M |
| -Cash and cash equivalents | 18.79%219.87M | 18.79%219.87M | 332.21%370.19M | 274.16%575.75M | 297.10%471.4M | -45.63%185.08M | -45.63%185.08M | -40.40%85.65M | 23.00%153.88M | -14.76%118.71M |
| -Short-term investments | 212.39%1.28B | 212.39%1.28B | 166.65%1.22B | 71.14%723.3M | -4.94%444.47M | 51.77%410.27M | 51.77%410.27M | 74.50%456.93M | 54.74%422.62M | 81.37%467.59M |
| Receivables | 227.29%28.22M | 227.29%28.22M | --19.21M | --15.71M | --9.04M | 122.53%8.62M | 122.53%8.62M | ---- | ---- | ---- |
| -Accounts receivable | --0 | --0 | --0 | --0 | --1.58M | -53.26%1.11M | -53.26%1.11M | ---- | ---- | ---- |
| -Accrued interest receivable | 275.39%28.22M | 275.39%28.22M | --19.21M | --15.71M | --7.47M | 397.55%7.52M | 397.55%7.52M | ---- | ---- | ---- |
| Prepaid assets | 71.43%12.57M | 71.43%12.57M | --14.06M | --14.04M | --9.56M | -12.07%7.33M | -12.07%7.33M | ---- | ---- | ---- |
| Other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 44.73%12.9M | 198.87%18.03M | 40.34%10.85M |
| Total current assets | 152.29%1.54B | 152.29%1.54B | 191.97%1.62B | 123.50%1.33B | 56.49%934.47M | -1.87%611.31M | -1.87%611.31M | 34.03%555.49M | 47.07%594.53M | 47.52%597.15M |
| Non current assets | ||||||||||
| Net PPE | 9.83%18.29M | 9.83%18.29M | -7.31%15.79M | -0.42%15.47M | 1.09%16.28M | 10.95%16.65M | 10.95%16.65M | 11.35%17.04M | -2.22%15.53M | 5.35%16.1M |
| -Gross PPE | 20.18%26.29M | 20.18%26.29M | 6.51%23.05M | 12.48%22.01M | 12.88%22.14M | 20.65%21.87M | 20.65%21.87M | 19.97%21.64M | 7.22%19.57M | 13.17%19.62M |
| -Accumulated depreciation | -53.17%-8M | -53.17%-8M | -57.60%-7.26M | -62.10%-6.55M | -66.96%-5.86M | -67.34%-5.22M | -67.34%-5.22M | -68.16%-4.61M | -70.54%-4.04M | -71.52%-3.51M |
| Other non current assets | 456.38%3.32M | 456.38%3.32M | 387.17%3.11M | 339.36%3.16M | -0.69%720K | -29.80%596K | -29.80%596K | -17.44%639K | 7.96%719K | -30.89%725K |
| Total non current assets | 25.26%21.61M | 25.26%21.61M | 6.95%18.91M | 14.61%18.62M | 1.02%17M | 8.77%17.25M | 8.77%17.25M | 9.96%17.68M | -1.81%16.25M | 3.02%16.83M |
| Total assets | 148.81%1.56B | 148.81%1.56B | 186.27%1.64B | 120.61%1.35B | 54.97%951.47M | -1.60%628.56M | -1.60%628.56M | 33.13%573.16M | 45.15%610.78M | 45.79%613.98M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -3.95%8.46M | -3.95%8.46M | 38.05%7.66M | 57.24%8.89M | -39.89%2.35M | 89.97%8.81M | 89.97%8.81M | --5.55M | --5.65M | --3.91M |
| -accounts payable | -3.95%8.46M | -3.95%8.46M | 38.05%7.66M | 57.24%8.89M | -39.89%2.35M | 89.97%8.81M | 89.97%8.81M | --5.55M | --5.65M | --3.91M |
| Current accrued expenses | 139.16%61.06M | 139.16%61.06M | 58.78%41.97M | 22.73%32.04M | 16.67%34.98M | -8.60%25.53M | -8.60%25.53M | --26.43M | --26.1M | --29.98M |
| Current debt and capital lease obligation | 5.63%3.84M | 5.63%3.84M | 5.61%3.8M | 19.49%3.77M | 19.08%3.73M | 17.20%3.64M | 17.20%3.64M | 16.57%3.6M | 2.71%3.15M | 23.00%3.13M |
| -Current capital lease obligation | 5.63%3.84M | 5.63%3.84M | 5.61%3.8M | 19.49%3.77M | 19.08%3.73M | 17.20%3.64M | 17.20%3.64M | 16.57%3.6M | 2.71%3.15M | 23.00%3.13M |
| Current deferred liabilities | -26.01%20.99M | -26.01%20.99M | 898.98%19.66M | 600.71%26.7M | 416.18%26.1M | 462.69%28.37M | 462.69%28.37M | -63.92%1.97M | -29.18%3.81M | -4.84%5.06M |
| Current liabilities | 21.49%98.02M | 21.49%98.02M | 87.48%91.33M | 86.13%84.21M | 55.88%74.96M | 55.43%80.68M | 55.43%80.68M | 14.18%48.72M | 34.31%45.24M | 55.51%48.09M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -52.41%2.96M | -52.41%2.96M | -45.59%3.8M | -27.43%4.62M | -22.29%5.42M | -18.06%6.21M | -18.06%6.21M | -14.73%6.98M | -27.32%6.36M | -25.37%6.98M |
| -Long term capital lease obligation | -52.41%2.96M | -52.41%2.96M | -45.59%3.8M | -27.43%4.62M | -22.29%5.42M | -18.06%6.21M | -18.06%6.21M | -14.73%6.98M | -27.32%6.36M | -25.37%6.98M |
| Non current deferred liabilities | -7.18%37.96M | -7.18%37.96M | --42.26M | --37.56M | --40.2M | 3,211.58%40.9M | 3,211.58%40.9M | --0 | --0 | --0 |
| Total non current liabilities | -13.15%40.92M | -13.15%40.92M | 559.95%46.06M | 562.95%42.18M | 553.96%45.62M | 434.32%47.11M | 434.32%47.11M | -35.92%6.98M | -50.15%6.36M | -51.91%6.98M |
| Total liabilities | 8.72%138.94M | 8.72%138.94M | 146.68%137.39M | 144.91%126.39M | 118.98%120.58M | 110.44%127.79M | 110.44%127.79M | 3.99%55.7M | 11.10%51.61M | 21.21%55.06M |
| Shareholders'equity | ||||||||||
| Share capital | 50.00%12K | 50.00%12K | 71.43%12K | 57.14%11K | 42.86%10K | 14.29%8K | 14.29%8K | 40.00%7K | 40.00%7K | 40.00%7K |
| -common stock | 50.00%12K | 50.00%12K | 71.43%12K | 57.14%11K | 42.86%10K | 14.29%8K | 14.29%8K | 40.00%7K | 40.00%7K | 40.00%7K |
| Retained earnings | -56.47%-893.07M | -56.47%-893.07M | -54.96%-790.81M | -55.12%-710.41M | -55.65%-639.62M | -59.19%-570.76M | -59.19%-570.76M | -65.65%-510.32M | -73.16%-457.96M | -87.83%-410.94M |
| Paid-in capital | 116.08%2.32B | 116.08%2.32B | 122.12%2.29B | 89.44%1.93B | 51.43%1.47B | 14.06%1.07B | 14.06%1.07B | 49.55%1.03B | 58.90%1.02B | 62.84%971.38M |
| Gains losses not affecting retained earnings | 2,221.60%2.9M | 2,221.60%2.9M | 478.17%7.1M | 83.01%-453K | 69.65%-464K | 104.63%125K | 104.63%125K | 45.77%-1.88M | 10.72%-2.67M | 24.53%-1.53M |
| Total stockholders'equity | 184.56%1.42B | 184.56%1.42B | 190.53%1.5B | 118.36%1.22B | 48.66%830.9M | -13.37%500.76M | -13.37%500.76M | 37.27%517.47M | 49.37%559.18M | 48.76%558.92M |
| Total equity | 184.56%1.42B | 184.56%1.42B | 190.53%1.5B | 118.36%1.22B | 48.66%830.9M | -13.37%500.76M | -13.37%500.76M | 37.27%517.47M | 49.37%559.18M | 48.76%558.92M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |